Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
about
Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathwayc-FLIP, a master anti-apoptotic regulatorFlavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cellsCombined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy.Landscape phage fusion protein-mediated targeting of nanomedicines enhances their prostate tumor cell association and cytotoxic efficiencyPARP-1 regulates resistance of pancreatic cancer to TRAIL therapy.Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells.Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer?Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells.Modulation of apoptotic pathways by human papillomaviruses (HPV): mechanisms and implications for therapy.Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide productionTo kill a tumor cell: the potential of proapoptotic receptor agonistsRegression of prostate cancer xenografts by RLIP76 depletion.Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3.Stem cells as vectors for antitumour therapy.Combined modality therapy with TRAIL or agonistic death receptor antibodies.TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.Receptor-based targeting of therapeutics.PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.A programmable microfluidic cell array for combinatorial drug screening.Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
P2860
Q21260429-CC5C472F-24FF-4916-8268-BD48A05378BAQ28391119-90303219-3C6D-4FA6-A9B9-C93518002B3CQ28817517-A0072E9D-CBA1-4343-AB17-6EECE987D17FQ33240972-B38C3E85-EAF7-48B2-8218-B83EE29E563BQ33392721-E383DC76-52C7-406B-BB8D-5E14090B4FF8Q33529963-FAFBAA10-95F5-4CF7-84CC-7CDB08A5D2D8Q33731141-2FC70DB0-6D9D-441B-92E8-C99ADBD99E5EQ35570425-B6C426DD-8782-4001-B253-1B298A2CADEBQ35762274-1798A99A-CCB1-4341-A47C-FD4A8BB5F7A1Q35827410-EEF991A5-5E1F-4C06-9BA1-BFEAC4CDB9BBQ36246491-5EA6CB09-6304-4DB0-A526-E9FFC59E53B4Q36482809-788F73C6-8D7A-42F7-B97E-BEDA6690F0C7Q36744130-46FE4BA5-5888-4D68-8E8C-D55B64EA607AQ37181734-1154E0F8-7C82-4850-BC88-536BA87DF8EEQ37194622-6BD95F3C-68A6-4500-BFD1-F95B6F42339DQ37520449-4072FF5C-D367-4398-807D-3A4D15ACE848Q37730300-A3538784-2736-4121-B911-0B0613553BA3Q37832083-49CA6463-BB5F-42B2-B6B0-E77E1D5BAE5FQ37972139-D2FDC601-1978-41F6-865E-BDBC43D05F9DQ38084739-25686489-C0B5-4D43-A909-D8425ECC1A03Q38926314-7F54CE32-A521-4170-A52A-2777D8788D8FQ39372646-57B15121-FADA-45FA-A984-5CD5D98DB393Q39702755-A5EDDBE4-F8B6-4F4D-BFA7-BA9EE6BF8E8CQ39985088-6DD6FAFC-8B8E-45FF-92C4-A4DBC00869C4
P2860
Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Doxorubicin increases the effe ...... of prostate cancer xenografts
@ast
Doxorubicin increases the effe ...... of prostate cancer xenografts
@en
Doxorubicin increases the effe ...... of prostate cancer xenografts
@nl
type
label
Doxorubicin increases the effe ...... of prostate cancer xenografts
@ast
Doxorubicin increases the effe ...... of prostate cancer xenografts
@en
Doxorubicin increases the effe ...... of prostate cancer xenografts
@nl
prefLabel
Doxorubicin increases the effe ...... of prostate cancer xenografts
@ast
Doxorubicin increases the effe ...... of prostate cancer xenografts
@en
Doxorubicin increases the effe ...... of prostate cancer xenografts
@nl
P2093
P2860
P356
P1433
P1476
Doxorubicin increases the effe ...... of prostate cancer xenografts
@en
P2093
Ahmed El-Zawahry
Christina Voelkel-Johnson
John McKillop
P2860
P2888
P356
10.1186/1471-2407-5-2
P407
P577
2005-01-07T00:00:00Z
P5875
P6179
1041982399